🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes

AI and Cancer Research ── Kidney ── 2026-10-17

A figure laying out two new kidney cancer AI papers side by side. The first, a two-institution retrospective study of 263 ccRCC patients, extracts ECV and AEF from contrast-enhanced CT and compares six ML models; logistic regression was best, with external test AUC 0.857, and ECV, tumor diameter and AEF were top predictors. The second is a preclinical study proposing DAG-DMobileNetV2 to grade RCC into 4 grades on histopathology images. Readers then compare data, method and evidence stage.
Image abstract — the whole article on one page (click to enlarge)
2 Kidney papers. Lead: Interpretable machine learning for preoperative prediction of WHO/ISUP grade in clear cell renal cell carcinoma using contrast-enhanced CT–derived extracellular volume fraction

Journals covered and how papers are chosen: see the index

Kidney cancer: treatment, trials and AI

← Back to this issue